Table 1. Clinical characteristics of the gastric cancer patients.
Expression of miR-421 | |||||
---|---|---|---|---|---|
Low | High | ||||
No. of patients | % | No. of patients | % | P value | |
Total | 20 | 87 | |||
Age | 0.394 | ||||
≤ 60 | 12 | 60.0 | 43 | 49.4 | |
> 60 | 8 | 40.0 | 44 | 50.6 | |
Gender | 0.563 | ||||
Male | 17 | 85.0 | 69 | 79.3 | |
Female | 3 | 15.0 | 18 | 20.7 | |
Tumor differention | 0.627 | ||||
Undifferentiation | 0 | 0 | 2 | 2.3 | |
Poor | 15 | 75.0 | 53 | 60.9 | |
Moderate | 5 | 15.0 | 31 | 35.7 | |
Well | 0 | 0 | 1 | 1.1 | |
Tumor stage | 0.150 | ||||
I–II | 8 | 40.0 | 21 | 24.1 | |
III–IV | 12 | 60.0 | 66 | 75.9 | |
Tumor site | 0.512 | ||||
Cardia | 3 | 15.0 | 25 | 28.8 | |
Fundus | 1 | 5.0 | 1 | 1.1 | |
Body | 10 | 50.0 | 36 | 41.4 | |
Antrum | 6 | 30.0 | 23 | 26.4 | |
Pylorus | 0 | 0 | 2 | 2.3 | |
Vascular invasion | 0.735 | ||||
Yes | 13 | 65.0 | 53 | 60.9 | |
No | 7 | 35.0 | 34 | 39.1 | |
Nerve invasion | 0.175 | ||||
Yes | 10 | 50.0 | 48 | 55.2 | |
No | 10 | 50.0 | 39 | 44.8 |